查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
北美类器官市场预测至 2030 年 - 区域分析 - 按器官类型、应用、来源和类型
市场调查报告书
商品编码
1420190

北美类器官市场预测至 2030 年 - 区域分析 - 按器官类型、应用、来源和类型

North America Organoids Market Forecast to 2030 - Regional Analysis - by Organ Type, Application, Source, and Type
出版日期: | 出版商: The Insight Partners | 英文 90 Pages | 订单完成后即时交付

价格

北美类器官市场预计将从2022年的11.2501亿美元成长到2030年的53.5972亿美元。预计2022年至2030年CAGR为21.5%。

个人化药物的日益普及推动了北美类器官市场

个人化医疗，也称为精准医疗，是一种根据预期的反应或疾病风险为个别患者量身定製程序或药物的医疗模式。根据个人化医疗联盟(PMC) 发表的一项研究，2005 年个人化药物仅占FDA 批准的新分子实体的5%，而2016 年则占了25% 以上。此外，占所有化合物和药物的42 % 73% 的研发中肿瘤化合物有潜力成为个人化药物。此外，生物製药公司在过去五年中对个人化药物的研发投入几乎翻了一番，未来五年可能会增加33%。生物製药研究人员也预测，未来五年个人化药物的开发将成长 69%。根据PMC的最新报告（2021年发布），在美国，市场上的个人化医疗数量已从2016年的132种上升到2020年的286种。该资料是透过追踪2008年以来的个人化医疗数量来共享的。由PMC。

使用类器官来创建个人化药物疗法为改善患者护理提供了令人兴奋的机会。此外，药剂师在增加个人化药物需求方面发挥着重要作用，因为他们积极宣传精准医疗并提高人们的意识。最近的研究表明，超过 50% 的消费者有兴趣购买客製化产品或服务。这种需求促使药物研究发展出更有针对性的治疗方法，使药物更安全、更有效。

个人化癌症医学是一种根据肿瘤基因组特征为每位患者制定有效治疗策略的方法。对个人化肿瘤模型研究的需求不断增加，以确认临床前环境中基因组药物反应预测的功能。许多研究强调了肿瘤类器官在个人化癌症医学中在基因药物关联治疗、新疗法鑑定和患者预后预测方面的应用。

个人化癌症治疗对每位患者进行特定的治疗。使用与原始肿瘤具有相似特征的个人化肿瘤模型可能会准确预测患者的药物反应。肿瘤类器官模型有几个优点，例如与预先存在的模型相比，保留了原始肿瘤的分子和细胞组成。这些优点凸显了肿瘤类器官在个人化癌症治疗中的巨大潜力，特别是在临床前药物筛选和预测患者对选定治疗方案的反应。

北美类器官市场概况

北美类器官市场分为美国、加拿大和墨西哥。 2022年，美国占据北美类器官市场最大份额。患有慢性病和病毒性疾病的患者数量不断增加、研发活动不断增加、类器官模型的商业化以及干细胞研究的突破是推动类器官市场的关键因素。此外，用于类器官开发的资金和赠款不断增加也有利于市场扩张。

北美类器官市场收入及 2030 年预测（百万美元）

北美类器官市场细分

北美类器官市场分为器官类型、应用、来源、类型和国家。

依器官类型，北美类器官市场分为肠、肝、胃、胰臟、肺、脑、肾等。 2022 年，肠道领域在北美类器官市场中占据最大份额。

根据应用，北美类器官市场分为发育生物学疾病、传染病病理学、再生医学、药物毒性和功效测试、药物发现和个人化医疗等。 2022 年，发育生物学疾病领域占据北美类器官市场的最大份额。

根据来源，北美类器官市场分为多能干细胞和器官特异性成体干细胞。 2022 年，多能干细胞细分市场在北美类器官市场中占据更大份额。

根据类型，北美类器官市场分为仪器、消耗品和服务。 2022 年，消耗品领域在北美类器官市场中占据最大份额。

根据国家/地区，北美类器官市场分为美国、加拿大和墨西哥。 2022 年，美国在北美类器官市场占据主导地位。

STEMCELL Technologies Inc、Cellesce Ltd、Organoid Therapeutics、3Dnamics Inc、Thermo Fisher Scientific Inc、Merck KGaA 和 InSphero 是北美类器官市场的一些领导公司。

目录

第 1 章：简介

  • Insight Partners 研究报告指南
  • 市场区隔

第 2 章：执行摘要

  • 北美主要见解
  • 北美市场吸引力

第 3 章：研究方法

  • 覆盖范围
  • 二次研究
  • 初步研究

第 4 章：北美类器官市场格局

  • 概述
  • 北美 PEST 分析

第 5 章：北美类器官市场 - 主要产业动态

  • 主要市场驱动因素：
    • 对肿瘤建模和生物样本库的需求不断增长
    • 越来越多地采用个人化药物
    • 人们日益关注开发动物测试模型的替代方案
  • 主要市场限制：
    • 与将类器官纳入现有工作流程相关的问题
    • 缺乏熟练的专业人员
  • 主要市场机会：
    • 专注于药物发现活动
  • 未来的趋势：
    • 将类器官与器官晶片结合
  • 影响分析：

第 6 章：类器官市场 - 北美市场分析

  • 北美类器官市场收入，2022 - 2030

第 7 章：北美类器官市场 - 2030 年收入与预测 - 按器官类型

  • 概述
  • 2022 年及 2030 年北美类器官市场收入份额，按器官类型划分 (%)
  • 胃
  • 肠
  • 肝
  • 胰臟
  • 肺
  • 脑
  • 肾
  • 其他的

第 8 章：北美类器官市场 - 2030 年收入和预测 -按应用

  • 概述
  • 2022 年及 2030 年北美类器官市场收入份额（按应用划分）
  • 发育生物学
  • 传染病的疾病病理学
  • 再生医学
  • 药物毒性和药效测试
  • 药物发现与个人化医疗
  • 其他的

第 9 章：北美类器官市场 - 收入和 2030 年预测 - 按来源

  • 概述
  • 2022 年及 2030 年北美类器官市场收入份额（按来源划分）（%）
  • 多能干细胞
  • 器官特异性成体干细胞

第 10 章：北美类器官市场 - 收入和 2030 年预测 - 按类型

  • 概述
  • 北美类器官市场收入份额，按类型 2022 年和 2030 年 (%)
  • 仪器
  • 耗材
  • 服务

第 11 章：北美类器官市场 - 国家分析

  • 北美洲
      • 我们
      • 加拿大
      • 墨西哥

第 12 章：COVID-19 前后的影响

  • Covid-19 前后的影响

第 13 章：北美类器官市场产业格局

  • 概述
  • 市场上公司采取的成长策略，(%)
  • 有机发展
    • 概述
  • 无机发展
    • 概述

第 14 章：北美类器官市场，主要公司概况

  • STEMCELL Technologies Inc.
  • Cellesce Ltd
  • Organoid Therapeutics
  • Thermo Fisher Scientific Inc
  • Merck KGaA
  • InSphero

第 15 章：附录

  • 关于我们
  • 专业术语
Product Code: TIPRE00018845

The North America organoid market is expected to grow from US$ 1,125.01 million in 2022 to US$ 5,359.72 million by 2030. It is estimated to grow at a CAGR of 21.5% from 2022 to 2030.

Growing Adoption of Personalized Drugs Fuel North America Organoids Market

Personalized medicine, also known as precision medicine, is a medical model that practices procedures or drugs tailored to the individual patient based on the projected response or risk of disease. According to a study published by Personalized Medicine Coalition (PMC), personalized medicines accounted for only 5% of the new FDA-approved molecular entities in 2005, whereas they accounted for more than 25% in 2016. Additionally, 42% of all compounds and 73% of oncology compounds in the pipeline have the potential to be personalized medicines. Moreover, biopharmaceutical companies nearly doubled their R&D investment in personalized drugs over the past five years, which is likely to increase by 33% in the next five years. Biopharmaceutical researchers also predict a 69% increase in the development of personalized medicines over the coming five years. According to the latest report by the PMC (published in 2021), in the US, the number of personalized medicines in the market has risen from 132 in 2016 to 286 in 2020. The data was shared by tracking the numbers of personalized medicine since 2008 by the PMC.

The implementation of organoids to create personalized drug therapies provides exciting opportunities for improving patient care. In addition, pharmacists play an essential role in increasing the demand for personalized medicines as they proactively educate and create awareness about precision medicine. Recent research has highlighted that more than 50% of consumers are interested in purchasing customized products or services. This demand has persuaded pharmaceutical research to develop more tailored treatments to make medicines safer and more effective.

Personalized cancer medicine is an approach to tailoring effective therapeutic strategies for each patient according to a tumor's genomic characterization. There is an increasing demand for research in personalized tumor modeling to confirm the functional aspects of genomic drug response predictions in the preclinical setting. Numerous studies have highlighted the application of tumor organoids in personalized cancer medicine in terms of gene-drug association treatment, identification of new therapies, and prediction of patient outcomes.

Personalized cancer therapy applies specific treatments to each patient. Using personalized tumor models with similar characteristics to the original tumors may result in accurate predictions of drug responses in patients. Tumor organoid models have several advantages, such as conserving the molecular and cellular composition of the original tumor over pre-existing models. These advantages highlight the tremendous potential of tumor organoids in personalized cancer therapy, particularly in preclinical drug screening and predicting patient responses to selected treatment regimens.

North America Organoids Market Overview

The North America organoids market is segmented into the US, Canada, and Mexico. In 2022, the US held the largest share of the North America organoids market. Rising number of patients suffering from chronic conditions and viral diseases, increasing activities in research and development, commercialization of organoid models, and breakthroughs in stem cell research are the key factors propelling the market for organoids. Also, the growing funding and grants for organoid development are favoring market expansion.

North America Organoid Market Revenue and Forecast to 2030 (US$ Million)

North America Organoids Market Segmentation

The North America organoid market is segmented into organ type, application, source, type, and country.

Based on organ type, the North America organoid market is segmented into intestine, liver, stomach, pancreas, lung, brain, kidney, and others. The intestine segment held the largest share of the North America organoid market in 2022.

Based on application, the North America organoid market is segmented into developmental biology disease, pathology of infectious disease, regenerative medicine, drug toxicity and efficacy testing, drug discovery and personalized medicine, and others. The developmental biology disease segment held the largest share of the North America organoid market in 2022.

Based on source, the North America organoid market is bifurcated into pluripotent stem cells and organ-specific adult stem cell. The pluripotent stem cells segment held a larger share of the North America organoid market in 2022.

Based on type, the North America organoid market is segmented into instruments, consumables, and services. The consumables segment held the largest share of the North America organoid market in 2022.

Based on country, the North America organoid market is segmented int o the US, Canada, and Mexico. The US dominated the North America organoid market in 2022.

STEMCELL Technologies Inc, Cellesce Ltd, Organoid Therapeutics, 3Dnamics Inc, Thermo Fisher Scientific Inc, Merck KGaA, and InSphero are some of the leading companies operating in the North America organoids market.

Reasons to Buy:

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the North America organoids market.
  • Highlights key business priorities in order to assist companies to realign their business strategies
  • The key findings and recommendations highlight crucial progressive industry trends in the North America organoids market, thereby allowing players across the value chain to develop effective long-term strategies
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
  • Scrutinize in-depth North America market trends and outlook coupled with the factors driving the organoids market, as well as those hindering it
  • Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 North America Key Insights
  • 2.2 North America Market Attractiveness

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. North America Organoids Market Landscape

  • 4.1 Overview
  • 4.2 North America PEST Analysis

5. North America Organoids Market - Key Industry Dynamics

  • 5.1 Key Market Drivers:
    • 5.1.1 Increasing Demand for Tumor Modeling and Biobanking
    • 5.1.2 Growing Adoption of Personalized Drugs
    • 5.1.3 Rising Focus on Developing Alternatives for Animal Testing Models
  • 5.2 Key Market Restraints:
    • 5.2.1 Issues Related to Incorporation of Organoids into Existing Workflows
    • 5.2.2 Dearth of Skilled Professionals
  • 5.3 Key Market Opportunities:
    • 5.3.1 Focus on Drug Discovery Activities
  • 5.4 Future Trends:
    • 5.4.1 Combining Organoid with Organ-On-A-Chip
  • 5.5 Impact Analysis:

6. Organoids Market - North America Market Analysis

  • 6.1 North America Organoids Market Revenue (US$ Mn), 2022 - 2030

7. North America Organoids Market - Revenue and Forecast to 2030 - by Organ Type

  • 7.1 Overview
  • 7.2 North America Organoids Market Revenue Share, by Organ Type 2022 & 2030 (%)
  • 7.3 Stomach
    • 7.3.1 Overview
    • 7.3.2 Stomach: North America Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.4 Intestine
    • 7.4.1 Overview
    • 7.4.2 Intestine: North America Organoids Market - Revenue and Forecast to 2030 (US$ Million)
    • 7.4.3
  • 7.5 Liver
    • 7.5.1 Overview
    • 7.5.2 Liver: North America Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.6 Pancreas
    • 7.6.1 Overview
    • 7.6.2 Pancreas: North America Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.7 Lung
    • 7.7.1 Overview
    • 7.7.2 Lung: North America Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.8 Brain
    • 7.8.1 Overview
    • 7.8.2 Brain: North America Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.9 Kidney
    • 7.9.1 Overview
    • 7.9.2 Kidney: North America Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.10 Others
    • 7.10.1 Overview
    • 7.10.2 Others: North America Organoids Market - Revenue and Forecast to 2030 (US$ Million)

8. North America Organoids Market - Revenue and Forecast to 2030 - by Application

  • 8.1 Overview
  • 8.2 North America Organoids Market Revenue Share, by Application 2022 & 2030 (%)
  • 8.3 Developmental Biology
    • 8.3.1 Overview
    • 8.3.2 Developmental Biology: North America Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.4 Disease Pathology of Infectious Disease
    • 8.4.1 Overview
    • 8.4.2 Disease Pathology of Infectious Disease: North America Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.5 Regenerative Medicine
    • 8.5.1 Overview
    • 8.5.2 Regenerative Medicine: North America Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.6 Drug Toxicity and Efficacy Testing
    • 8.6.1 Overview
    • 8.6.2 Drug Toxicity and Efficacy Testing: North America Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.7 Drug Discovery and Personalized Medicine
    • 8.7.1 Overview
    • 8.7.2 Drug Discovery and Personalized Medicine: North America Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.8 Others
    • 8.8.1 Overview
    • 8.8.2 Others: North America Organoids Market - Revenue and Forecast to 2030 (US$ Million)

9. North America Organoids Market - Revenue and Forecast to 2030 - by Source

  • 9.1 Overview
  • 9.2 North America Organoids Market Revenue Share, by Source 2022 & 2030 (%)
  • 9.3 Pluripotent Stem Cells
    • 9.3.1 Overview
    • 9.3.2 Pluripotent Stem Cells: North America Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.4 Organ-specific Adult Stem Cells
    • 9.4.1 Overview
    • 9.4.2 Organ-specific Adult Stem Cells: North America Organoids Market - Revenue and Forecast to 2030 (US$ Million)

10. North America Organoids Market - Revenue and Forecast to 2030 - by Type

  • 10.1 Overview
  • 10.2 North America Organoids Market Revenue Share, by Type 2022 & 2030 (%)
  • 10.3 Instruments
    • 10.3.1 Overview
    • 10.3.2 Instruments: North America Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • 10.4 Consumables
    • 10.4.1 Overview
    • 10.4.2 Consumables: North America Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • 10.5 Services
    • 10.5.1 Overview
    • 10.5.2 Services: North America Organoids Market - Revenue and Forecast to 2030 (US$ Million)

11. North America Organoids Market - Country Analysis

  • 11.1 North America: Overview
    • 11.1.1 North America Organoids Market, by Country
      • 11.1.1.1 US
        • 11.1.1.1.1 Overview
        • 11.1.1.1.2 US Organoids Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.1.1.1.3 US Organoids Market, by Organ Type
        • 11.1.1.1.4 US Organoids Market, by Application
        • 11.1.1.1.5 US Organoids Market, by Source
        • 11.1.1.1.6 US Organoids Market, by Type
      • 11.1.1.2 Canada
        • 11.1.1.2.1 Overview
        • 11.1.1.2.2 Canada Organoids Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.1.1.2.3 Canada Organoids Market, by Organ Type
        • 11.1.1.2.4 Canada Organoids Market, by Application
        • 11.1.1.2.5 Canada Organoids Market, by Source
        • 11.1.1.2.6 Canada Organoids Market, by Type
      • 11.1.1.3 Mexico
        • 11.1.1.3.1 Overview
        • 11.1.1.3.2 Mexico Organoids Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.1.1.3.3 Mexico Organoids Market, by Organ Type
        • 11.1.1.3.4 Mexico Organoids Market, by Application
        • 11.1.1.3.5 Mexico Organoids Market, by Source
        • 11.1.1.3.6 Mexico Organoids Market, by Type

12. Pre & Post COVID-19 Impact

  • 12.1 Pre & Post Covid-19 Impact

13. North America Organoids Market Industry Landscape

  • 13.1 Overview
  • 13.2 Growth Strategies Done by the Companies in the Market, (%)
  • 13.3 Organic Developments
    • 13.3.1 Overview
  • 13.4 Inorganic Developments
    • 13.4.1 Overview

14. North America Organoids Market, Key Company Profiles

  • 14.1 STEMCELL Technologies Inc.
    • 14.1.1 Key Facts
    • 14.1.2 Business Description
    • 14.1.3 Products and Services
    • 14.1.4 Financial Overview
    • 14.1.5 SWOT Analysis
    • 14.1.6 Key Developments
  • 14.2 Cellesce Ltd
    • 14.2.1 Key Facts
    • 14.2.2 Business Description
    • 14.2.3 Products and Services
    • 14.2.4 Financial Overview
    • 14.2.5 SWOT Analysis
    • 14.2.6 Key Developments
  • 14.3 Organoid Therapeutics
    • 14.3.1 Key Facts
    • 14.3.2 Business Description
    • 14.3.3 Products and Services
    • 14.3.4 Financial Overview
    • 14.3.5 SWOT Analysis
    • 14.3.6 Key Developments
    • 14.4.3Dnamics Inc.
    • 14.4.1 Key Facts
    • 14.4.2 Business Description
    • 14.4.3 Products and Services
    • 14.4.4 Financial Overview
    • 14.4.5 SWOT Analysis
    • 14.4.6 Key Developments
  • 14.5 Thermo Fisher Scientific Inc
    • 14.5.1 Key Facts
    • 14.5.2 Business Description
    • 14.5.3 Products and Services
    • 14.5.4 Financial Overview
    • 14.5.5 SWOT Analysis
    • 14.5.6 Key Developments
  • 14.6 Merck KGaA
    • 14.6.1 Key Facts
    • 14.6.2 Business Description
    • 14.6.3 Products and Services
    • 14.6.4 Financial Overview
    • 14.6.5 SWOT Analysis
    • 14.6.6 Key Developments
  • 14.7 InSphero
    • 14.7.1 Key Facts
    • 14.7.2 Business Description
    • 14.7.3 Products and Services
    • 14.7.4 Financial Overview
    • 14.7.5 SWOT Analysis
    • 14.7.6 Key Developments

15. Appendix

  • 15.1 About Us
  • 15.2 Glossary of Terms

List Of Tables

  • Table 1. North America Organoids Market Segmentation
  • Table 2. US Organoids Market Revenue and Forecast to 2030 (US$ Mn) - Organ Type
  • Table 3. US Organoids Market Revenue and Forecast to 2030 (US$ Mn) - Application
  • Table 4. US Organoids Market Revenue and Forecast to 2030 (US$ Mn) - Source
  • Table 5. US Organoids Market Revenue and Forecast to 2030 (US$ Mn) - Type
  • Table 6. Canada Organoids Market Revenue and Forecast to 2030 (US$ Mn) - Organ Type
  • Table 7. Canada Organoids Market Revenue and Forecast to 2030 (US$ Mn) - Application
  • Table 8. Canada Organoids Market Revenue and Forecast to 2030 (US$ Mn) - Source
  • Table 9. Canada Organoids Market Revenue and Forecast to 2030 (US$ Mn) - Type
  • Table 10. Mexico Organoids Market Revenue and Forecast to 2030 (US$ Mn) - Organ Type
  • Table 11. Mexico Organoids Market Revenue and Forecast to 2030 (US$ Mn) - Application
  • Table 12. Mexico Organoids Market Revenue and Forecast to 2030 (US$ Mn) - Source
  • Table 13. Mexico Organoids Market Revenue and Forecast to 2030 (US$ Mn) - Type
  • Table 14. Organic Developments Done by Companies
  • Table 15. Inorganic Developments Done by Companies
  • Table 16. Glossary of Terms, North America Organoids Market

List Of Figures

  • Figure 1. North America Organoids Market Segmentation, By Country
  • Figure 2. North America - PEST Analysis
  • Figure 3. North America Organoids Market - Key Industry Dynamics
  • Figure 4. Impact Analysis of Drivers and Restraints
  • Figure 5. North America Organoids Market Revenue (US$ Mn), 2022 - 2030
  • Figure 6. North America Organoids Market Revenue Share, by Organ Type 2022 & 2030 (%)
  • Figure 7. Stomach: North America Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 8. Intestine: North America Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 9. Liver: North America Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 10. Pancreas: North America Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 11. Lung: North America Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 12. Brain: North America Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 13. Kidney: North America Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 14. Others: North America Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 15. North America Organoids Market Revenue Share, by Application 2022 & 2030 (%)
  • Figure 16. Developmental Biology: North America Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 17. Disease Pathology of Infectious Disease: North America Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 18. Regenerative Medicine: North America Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 19. Drug Toxicity and Efficacy Testing: North America Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 20. Drug Discovery and Personalized Medicine: North America Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 21. Others: North America Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 22. North America Organoids Market Revenue Share, by Source 2022 & 2030 (%)
  • Figure 23. Pluripotent Stem Cells: North America Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 24. Organ-specific Adult Stem Cells: North America Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 25. North America Organoids Market Revenue Share, by Type 2022 & 2030 (%)
  • Figure 26. Instruments: North America Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 27. Consumables: North America Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 28. Services: North America Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 29. Organoids Market, 2022 (US$Mn)
  • Figure 30. North America Organoids Market, By Key Countries, 2022 And 2030 (%)
  • Figure 31. US Organoids Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 32. Canada Organoids Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 33. Mexico Organoids Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 34. Pre & Post Covid-19 Impact
  • Figure 35. Growth Strategies Done by the Companies in the Market, (%)